Showing results (1-10 of 273) with videos related to
Sort By:
Pageof 28
Seminars in Thrombosis and Hemostasis|February 28, 2022
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for CliniciansHanny Al-SamkariHematology. American Society of Hematology. Education Program|December 9, 2022
Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problemHanny Al-SamkariBlood|November 10, 2020
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of careHanny Al-SamkariBlood Reviews|November 1, 2023
Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonistsHanny Al-SamkariResearch and Practice in Thrombosis and Haemostasis|September 2, 2025
Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?Hanny Al-SamkariPediatric Blood & Cancer|November 14, 2024
Mitapivat for Acquired Pyruvate Kinase DeficiencyHanny Al-SamkariAmerican Journal of Hematology|August 6, 2024
2025 update on clinical trials in immune thrombocytopeniaHanny Al-SamkariJournal of Thrombosis and Haemostasis : JTH|April 30, 2021
Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancyNathan Watson, Hanny Al-SamkariActa Haematologica|July 24, 2020
An Eltrombopag Red (Plasma) AlertHanny Al-Samkari, Katayoon GoodarziPageof 28